Radiotherapy Dosage

• 

  Subject Areas on Research

  • "Anatomically-correct" dosimetric parameters may be better predictors for esophageal toxicity than are traditional CT-based metrics. 
  • 125I embedded in an orbital prosthesis for retreatment of recurrent retinoblastoma. 
  • 167 Reducing Radiation an Order of Magnitude During Fluoroscopic-Guided Kyphoplasty. 
  • 70 Gy thoracic radiotherapy is feasible concurrent with chemotherapy for limited-stage small-cell lung cancer: analysis of Cancer and Leukemia Group B study 39808. 
  • A "rolling average" multiple adaptive planning method to compensate for target volume changes in image-guided radiotherapy of prostate cancer. 
  • A Phase I study of capecitabine, carboplatin, and paclitaxel with external beam radiation therapy for esophageal carcinoma. 
  • A TCP model incorporating setup uncertainty and tumor cell density variation in microscopic extension to guide treatment planning. 
  • A comparison of clinical and dosimetric outcomes in patients receiving partial breast irradiation with photon-only versus mixed photon/electron treatment plans. 
  • A comparison of conventional 'forward planning' with inverse planning for 3D conformal radiotherapy of the prostate. 
  • A comprehensive investigation of the accuracy and reproducibility of a multitarget single isocenter VMAT radiosurgery technique. 
  • A computer simulated phantom study of tomotherapy dose optimization based on probability density functions (PDF) and potential errors caused by low reproducibility of PDF. 
  • A detrimental effect of a combined chemotherapy-radiotherapy approach in children with diffuse intrinsic brain stem gliomas? 
  • A dose calculation method including scatter for IMRT optimization. 
  • A dose-volume-based tool for evaluating and ranking IMRT treatment plans. 
  • A feasibility study using radiochromic films for fast neutron 2D passive dosimetry. 
  • A knowledge-based approach to improving and homogenizing intensity modulated radiation therapy planning quality among treatment centers: an example application to prostate cancer planning. 
  • A method to study the characteristics of 3D dose distributions created by superposition of many intensity-modulated beams delivered via a slit aperture with multiple absorbing vanes. 
  • A methodology for selecting the beam arrangement to reduce the intensity-modulated radiation therapy (IMRT) dose to the SPECT-defined functioning lung. 
  • A methodology for using SPECT to reduce intensity-modulated radiation therapy (IMRT) dose to functioning lung. 
  • A novel needle-based miniature x-ray generating system. 
  • A pencil beam dose calculation model for CyberKnife system. 
  • A phase 1 trial of preoperative partial breast radiation therapy: Patient selection, target delineation, and dose delivery. 
  • A phase 1b trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignancies. 
  • A phase I study of UFT/leucovorin, carboplatin, and paclitaxel in combination with external beam radiation therapy for advanced esophageal carcinoma. 
  • A phase I study of the combination of sorafenib with temozolomide and radiation therapy for the treatment of primary and recurrent high-grade gliomas. 
  • A phase I/II trial of twice daily irradiation and concurrent chemotherapy for locally advanced squamous cell carcinoma of the head and neck. 
  • A phase II study of external beam radiotherapy combined with permanent source brachytherapy for intermediate-risk, clinically localized adenocarcinoma of the prostate: preliminary results of RTOG P-0019. 
  • A phase II study of induction chemotherapy followed by thoracic radiotherapy and erlotinib in poor-risk stage III non-small-cell lung cancer: results of CALGB 30605 (Alliance)/RTOG 0972 (NRG). 
  • A planning quality evaluation tool for prostate adaptive IMRT based on machine learning. 
  • A polymorphism within the promoter of the TGFβ1 gene is associated with radiation sensitivity using an objective radiologic endpoint. 
  • A pooled analysis of limited-stage small-cell lung cancer patients treated with induction chemotherapy followed by concurrent platinum-based chemotherapy and 70 Gy daily radiotherapy: CALGB 30904. 
  • A practical three-dimensional dosimetry system for radiation therapy. 
  • A prospective cohort study of late sequelae of pediatric allogeneic hematopoietic stem cell transplantation. 
  • A prospective feasibility study of respiratory-gated proton beam therapy for liver tumors. 
  • A prospective study of short-course radiotherapy in poor prognosis glioblastoma multiforme. 
  • A quality assurance method that utilizes 3D dosimetry and facilitates clinical interpretation. 
  • A randomized phase II study of 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy compared with bevacizumab plus 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy for intermediate-stage and T4N0-1 head and neck cancers. 
  • A round-robin gamma stereotactic radiosurgery dosimetry interinstitution comparison of calibration protocols. 
  • A simple model predicts freedom from biochemical recurrence after low-dose rate prostate brachytherapy alone. 
  • A singular value decomposition linear programming (SVDLP) optimization technique for circular cone based robotic radiotherapy. 
  • A technique of automating compensator design for lung inhomogeneity correction using an electron portal imaging device. 
  • ACR Appropriateness Criteria(®) Aggressive Nonmelanomatous Skin Cancer of the Head and Neck. 
  • ACR appropriateness criteria on external beam radiation therapy treatment planning for clinically localized prostate cancer expert panel on radiation oncology--prostate. 
  • AI-guided parameter optimization in inverse treatment planning. 
  • ANZCCSG BabyBrain99; intensified systemic chemotherapy, second look surgery and involved field radiation in young children with central nervous system malignancy. 
  • Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy. 
  • Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). 
  • Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). 
  • Accelerated partial breast irradiation: caution and concern from an ASTRO task force. 
  • Accelerated repopulation: friend or foe? Exploiting changes in tumor growth characteristics to improve the "efficiency" of radiotherapy. 
  • Accuracy of inhomogeneity correction in photon radiotherapy from CT scans with different settings. 
  • Acute and late toxicity of patients with inflammatory bowel disease undergoing irradiation for abdominal and pelvic neoplasms. 
  • Adaptive prediction of internal target motion using external marker motion: a technical study. 
  • Adaptive radiation therapy: technical components and clinical applications. 
  • Adenoid cystic carcinoma of the paranasal sinuses. 
  • Adjuvant external-beam radiotherapy with concurrent chemotherapy after resection of primary gallbladder carcinoma: a 23-year experience. 
  • Adjuvant therapy for pancreatic cancer: current status and future directions. 
  • Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114. 
  • Advances in treatment techniques: arc-based and other intensity modulated therapies. 
  • Algorithm and performance of a clinical IMRT beam-angle optimization system. 
  • Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: a randomized trial of two irradiation regimens. 
  • Alternating irradiation and chemotherapy in stage III A and B nonsmall cell lung cancer: report of a cancer and Leukemia Group B phase II study 8636. 
  • American Brachytherapy Society: Brachytherapy treatment recommendations for locally advanced cervix cancer for low-income and middle-income countries. 
  • American College of Radiology Appropriateness Criteria(®) treatment of stage I T1 glottic cancer. 
  • American Society for Radiation Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the transperineal permanent brachytherapy of prostate cancer. 
  • American Society of Radiation Oncology recommendations for documenting intensity-modulated radiation therapy treatments. 
  • An analysis of radiotherapy data from the CNS cancer consortium's randomized prospective trial comparing AZQ to BCNU in the treatment of patients with primary malignant brain tumors. The CNS cancer consortium. 
  • An automatic CT-guided adaptive radiation therapy technique by online modification of multileaf collimator leaf positions for prostate cancer. 
  • An effective preoperative three-dimensional radiotherapy target volume for extremity soft tissue sarcoma and the effect of margin width on local control. 
  • An evaluation of the relationship between the quality of prophylactic cranial radiotherapy in childhood acute leukemia and institutional experience: a Quality Assurance Review Center-Pediatric Oncology Group study. 
  • An investigation into the dosimetry of a nine-field tomotherapy irradiation using BANG-gel dosimetry. 
  • An investigation of PRESAGE® 3D dosimetry for IMRT and VMAT radiation therapy treatment verification. 
  • An investigation of the accuracy of an IMRT dose distribution using two- and three-dimensional dosimetry techniques. 
  • Analysis and minimization of overtraining effect in rule-based classifiers for computer-aided diagnosis. 
  • Analysis of prognostic variables which influence early and long-term response of pet animal tumors to radiation alone and radiation plus heat. 
  • Analysis of results of radiation therapy for Stage II carcinoma of the cervix. 
  • Anatomic tumor location influences the success of contemporary limb-sparing surgery and radiation among adults with soft tissue sarcomas of the extremities. 
  • Anesthesia for pediatric external beam radiation therapy. 
  • Apparatus-dependent dosimetric differences in spine stereotactic body radiotherapy. 
  • Appendiceal carcinoma: patterns of failure following surgery and implications for adjuvant therapy. 
  • Application of Gafchromic film in the dosimetry of an intravascular brachytherapy source. 
  • Application of dose compensation in image-guided radiotherapy of prostate cancer. 
  • Assessment of Treatment Response With Diffusion-Weighted MRI and Dynamic Contrast-Enhanced MRI in Patients With Early-Stage Breast Cancer Treated With Single-Dose Preoperative Radiotherapy: Initial Results. 
  • Assessment of the residual error in soft tissue setup in patients undergoing partial breast irradiation: results of a prospective study using cone-beam computed tomography. 
  • Association Between Incomplete Neoadjuvant Radiotherapy and Survival for Patients With Locally Advanced Rectal Cancer. 
  • Association between RT-induced changes in lung tissue density and global lung function. 
  • Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. 
  • Beam orientation selection for intensity-modulated radiation therapy based on target equivalent uniform dose maximization. 
  • Beam-orientation customization using an artificial neural network. 
  • Benchmark Credentialing Results for NRG-BR001: The First National Cancer Institute-Sponsored Trial of Stereotactic Body Radiation Therapy for Multiple Metastases. 
  • Biomarkers for Predicting Radiation Response. 
  • Body mass index, dose to organs at risk during vaginal brachytherapy, and the role of three-dimensional CT-based treatment planning. 
  • Brachial plexopathy in apical non-small cell lung cancer treated with definitive radiation: dosimetric analysis and clinical implications. 
  • Breast cancer following spinal irradiation for a childhood cancer: A report from the Childhood Cancer Survivor Study. 
  • Bronchial stenosis: an underreported complication of high-dose external beam radiotherapy for lung cancer? 
  • CNS prophylaxis in acute lymphoblastic leukemia: comparison of two methods a Southwest Oncology Group study. 
  • Carcinoma of the ampulla of Vater: patterns of failure following resection and benefit of chemoradiotherapy. 
  • Carcinoma of the uterine cervix: a 3D - CT analysis of dose to the internal, external and common iliac nodes in tandem and ovoid applications. 
  • Cardiac perfusion changes in patients treated for breast cancer with radiation therapy and doxorubicin: preliminary results. 
  • Cataracts after bone marrow transplantation: long-term follow-up of adults treated with fractionated total body irradiation. 
  • Challenges in the clinical application of advanced technologies to reduce radiation-associated normal tissue injury. 
  • Chemoradiation for localized pancreatic cancer: another perspective. 
  • Chemoradiation for patients with large-volume laryngeal cancers. 
  • Chemoradiotherapy for locoregionally advanced squamous cell carcinoma of the base of tongue. 
  • Chemoreirradiation for recurrent salivary gland malignancies. 
  • Chemotherapy and radiation therapy of human medulloblastoma in athymic nude mice. 
  • Chemotherapy followed by accelerated fractionated radiation for larynx preservation in patients with advanced laryngeal cancer. 
  • Chest Wall Deformity in the Radiation Oncology Clinic. 
  • Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy. 
  • Clear cell sarcoma of the gastrointestinal tract after very low-dose therapeutic radiation therapy: a case report. 
  • Clinical and dosimetric predictors of radiation-induced esophageal toxicity. 
  • Clinical application of intensity-modulated radiotherapy for locally advanced cervical cancer. 
  • Clinical assessment and characterization of a dual tube kilovoltage X-ray localization system in the radiotherapy treatment room. 
  • Clinical commissioning and use of the Novalis Tx linear accelerator for SRS and SBRT. 
  • Clinical practice guidance for radiotherapy planning after induction chemotherapy in locoregionally advanced head-and-neck cancer. 
  • Colorectal liver metastasis after 90Y radioembolization therapy: pilot study of change in MDCT attenuation as a surrogate marker for future FDG PET response. 
  • Combined modality therapy for rectal cancer: the relative value of posttreatment versus pretreatment CEA as a prognostic marker for disease recurrence. 
  • Combined vascular endothelial growth factor-targeted therapy and radiotherapy for rectal cancer: theory and clinical practice. 
  • Combined-modality therapy for early-stage Hodgkin lymphoma: maintaining high cure rates while minimizing risks. 
  • Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: cure balanced against complications. 
  • Combining gemcitabine with radiation in pancreatic cancer: understanding important variables influencing the therapeutic index. 
  • Combining multiple models to generate consensus: application to radiation-induced pneumonitis prediction. 
  • Combining scatter reduction and correction to improve image quality in cone-beam computed tomography (CBCT). 
  • Commissioning a CT-compatible LDR tandem and ovoid applicator using Monte Carlo calculation and 3D dosimetry. 
  • Comparing digital tomosynthesis to cone-beam CT for position verification in patients undergoing partial breast irradiation. 
  • Comparison of 3D conformal breast radiation treatment plans using the anisotropic analytical algorithm and pencil beam convolution algorithm. 
  • Comparison of Patient- and Practitioner-Reported Toxic Effects Associated With Chemoradiotherapy for Head and Neck Cancer. 
  • Comparison of three concomitant boost techniques for early-stage breast cancer. 
  • Comparison of treatment techniques for conformal radiotherapy of the prostate using dose-volume histograms and normal tissue complication probabilities. 
  • Complete pathologic response after chemoradiation for rectal cancer. 
  • Complete response to neoadjuvant chemoradiation for rectal cancer does not influence survival. 
  • Concurrent capecitabine and upper abdominal radiation therapy is well tolerated. 
  • Concurrent stereotactic radiosurgery and bevacizumab in recurrent malignant gliomas: a prospective trial. 
  • Cone-beam-CT guided radiation therapy: technical implementation. 
  • Conformal radiation therapy treatment planning reduces the dose to the optic structures for patients with tumors of the paranasal sinuses. 
  • Conformal radiation therapy with fixed shaped coplanar or noncoplanar radiation beam bouquets: a possible alternative to radiosurgery. 
  • Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with dynamic multileaf collimation. 
  • Contouring variations and the role of atlas in non-small cell lung cancer radiation therapy: Analysis of a multi-institutional preclinical trial planning study. 
  • Cost Implications of an Evidence-Based Approach to Radiation Treatment After Lumpectomy for Early-Stage Breast Cancer. 
  • Current Opportunities and Future Vision of Precision Medicine in Radiation Oncology. 
  • Cyberknife hypofractionated stereotactic radiosurgery (HSRS) of resection cavity after excision of large cerebral metastasis: efficacy and safety of an 800 cGy × 3 daily fractions regimen. 
  • Daily bone alignment with limited repeat CT correction rivals daily ultrasound alignment for prostate radiotherapy. 
  • Definitive dose thoracic radiation therapy in oligometastatic non-small cell lung cancer: A hypothesis-generating study. 
  • Delivery efficiency of an Elekta linac under gated operation. 
  • Determining the optimal block margin on the planning target volume for extracranial stereotactic radiotherapy. 
  • Development and Preliminary Evaluation of a Murine Model of Chronic Radiation-Induced Proctitis. 
  • Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer. 
  • Development of a 3D remote dosimetry protocol compatible with MRgIMRT. 
  • Development of a neuro-fuzzy technique for automated parameter optimization of inverse treatment planning. 
  • Development of an accurate EPID-based output measurement and dosimetric verification tool for electron beam therapy. 
  • Diode-based transmission detector for IMRT delivery monitoring: a validation study. 
  • Diode-based transmission detector for IMRT delivery monitoring: a validation study. 
  • Docetaxel enhances tumor radioresponse in vivo. 
  • Does vocal cord fixation preclude nonsurgical management of laryngeal cancer? 
  • Dose as a function of lung volume and planned treatment volume in helical tomotherapy intensity-modulated radiation therapy-based stereotactic body radiation therapy for small lung tumors. 
  • Dose response explorer: an integrated open-source tool for exploring and modelling radiotherapy dose-volume outcome relationships. 
  • Dose sculpting with generalized equivalent uniform dose. 
  • Dosimetric Analysis of Microscopic Disease in SBRT for Lung Cancers. 
  • Dosimetric Predictors of Patient-Reported Xerostomia and Dysphagia With Deintensified Chemoradiation Therapy for HPV-Associated Oropharyngeal Squamous Cell Carcinoma. 
  • Dosimetric analysis of the alopecia preventing effect of hippocampus sparing whole brain radiation therapy. 
  • Dosimetric and radiobiologic comparison of 3D conformal versus intensity modulated planning techniques for prostate bed radiotherapy. 
  • Dosimetric assessment of rigid setup error by CBCT for HN-IMRT. 
  • Dosimetric characteristics of novalis Tx system with high definition multileaf collimator. 
  • Dosimetric comparison of 6 MV and 15 MV single arc rapidarc to helical TomoTherapy for the treatment of pancreatic cancer. 
  • Dosimetric comparison of four target alignment methods for prostate cancer radiotherapy. 
  • Dosimetric comparison of preoperative single-fraction partial breast radiotherapy techniques: 3D CRT, noncoplanar IMRT, coplanar IMRT, and VMAT. 
  • Dosimetric effect of translational and rotational errors for patients undergoing image-guided stereotactic body radiotherapy for spinal metastases. 
  • Dosimetric effects of rotational offsets in stereotactic body radiation therapy (SBRT) for lung cancer. 
  • Dosimetric feasibility of cone-beam CT-based treatment planning compared to CT-based treatment planning. 
  • Dosimetric quantifiers for low-dose-rate prostate brachytherapy: is V(100) superior to D(90)? 
  • Dosimetric study using different leaf-width MLCs for treatment planning of dynamic conformal arcs and intensity-modulated radiosurgery. 
  • Dosimetric verification of lung cancer treatment using the CBCTs estimated from limited-angle on-board projections. 
  • Dosimetry and microdosimetry of targeted radiotherapy. 
  • Dosimetry of 131I-labeled 81C6 monoclonal antibody administered into surgically created resection cavities in patients with malignant brain tumors. 
  • Dosimetry tools and techniques for IMRT. 
  • Double blind randomized trial of sucralfate vs placebo during radical radiotherapy for head and neck cancers. 
  • Duodenal adenocarcinoma: patterns of failure after resection and the role of chemoradiotherapy. 
  • Dynamic contrast-enhanced magnetic resonance imaging as a predictor of clinical outcome in canine spontaneous soft tissue sarcomas treated with thermoradiotherapy. 
  • Dynamic electron arc radiotherapy (DEAR): a feasibility study. 
  • Dynamic simulation of motion effects in IMAT lung SBRT. 
  • Early cardiac perfusion defects after left-sided radiation therapy for breast cancer: is there a volume response? 
  • Early results with combined modality therapy for carcinoma of the esophagus. 
  • Editorial comment. 
  • Effect of increasing experience on dosimetric and clinical outcomes in the management of malignant pleural mesothelioma with intensity-modulated radiation therapy. 
  • Effect of patient setup errors on simultaneously integrated boost head and neck IMRT treatment plans. 
  • Effect of the first day correction on systematic setup error reduction. 
  • Effective pelvic symptom control using initial chemoradiation without colostomy in metastatic rectal cancer. 
  • Efficacy and Safety of Low-Dose Iodine Plaque Brachytherapy for Juxtapapillary Choroidal Melanoma. 
  • Efficacy endpoints of radiation therapy group protocol 0247: a randomized, phase 2 study of neoadjuvant radiation therapy plus concurrent capecitabine and irinotecan or capecitabine and oxaliplatin for patients with locally advanced rectal cancer. 
  • Emerging role of intensity-modulated radiation therapy in anorectal cancer. 
  • Endobronchial interstitial Au-198 implantation in the treatment of recurrent bronchogenic carcinoma. 
  • Equivalent uniform dose, D(90), and V(100) correlation with biochemical control after low-dose-rate prostate brachytherapy for clinically low-risk prostate cancer. 
  • Establishing the feasibility of the dosimetric compliance criteria of RTOG 1308: phase III randomized trial comparing overall survival after photon versus proton radiochemotherapy for inoperable stage II-IIIB NSCLC. 
  • Estimation of therapeutic gain in clinical trials involving hyperthermia and radiotherapy. 
  • Etoposide, vincristine, and cyclosporin A with standard-dose radiation therapy in newly diagnosed diffuse intrinsic brainstem gliomas: a pediatric oncology group phase I study. 
  • Evaluation of a 2D diode array for IMRT quality assurance. 
  • Evaluation of an artificial intelligence guided inverse planning system: clinical case study. 
  • Evaluation of multiple image-based modalities for image-guided radiation therapy (IGRT) of prostate carcinoma: a prospective study. 
  • Evaluations of an adaptive planning technique incorporating dose feedback in image-guided radiotherapy of prostate cancer. 
  • Experimental 3D dosimetry around a high-dose-rate clinical 192Ir source using a polyacrylamide gel (PAG) dosimeter. 
  • Extension of the NCAT phantom for the investigation of intra-fraction respiratory motion in IMRT using 4D Monte Carlo. 
  • Extracellular pH and P-31 magnetic resonance spectroscopic variables are related to outcome in canine soft tissue sarcomas treated with thermoradiotherapy. 
  • Feasibility of flap reconstruction in conjunction with intraoperative radiation therapy for advanced and recurrent head and neck cancer. 
  • Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer. 
  • Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck Cancer. 
  • Final results of a study of escalating doses of hyperfractionated radiotherapy in brain stem tumors in children: a Pediatric Oncology Group study. 
  • Fitting NTCP models to bladder doses and acute urinary symptoms during post-prostatectomy radiotherapy. 
  • Four-dimensional image-based treatment planning: Target volume segmentation and dose calculation in the presence of respiratory motion. 
  • Four-dimensional patient dose reconstruction for scanned ion beam therapy of moving liver tumors. 
  • From active shape model to active optical flow model: a shape-based approach to predicting voxel-level dose distributions in spine SBRT. 
  • Functional organ preservation with definitive chemoradiotherapy for T4 laryngeal squamous cell carcinoma. 
  • Functional polymorphisms of base excision repair genes XRCC1 and APEX1 predict risk of radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy. 
  • Functional promoter variant rs2868371 of HSPB1 is associated with risk of radiation pneumonitis after chemoradiation for non-small cell lung cancer. 
  • Future directions in toxicity prevention. 
  • Fuzzy logic guided inverse treatment planning. 
  • Generating arbitrary one-dimensional dose profiles using rotational therapy. 
  • Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer. 
  • Genotypes and haplotypes of the VEGF gene and survival in locally advanced non-small cell lung cancer patients treated with chemoradiotherapy. 
  • Geometric and dosimetric evaluations of an online image-guidance strategy for 3D-CRT of prostate cancer. 
  • HSPB1 gene polymorphisms predict risk of mortality for US patients after radio(chemo)therapy for non-small cell lung cancer. 
  • Halogenated pyrimidine sensitization of low dose rate irradiation in human malignant glioma. 
  • Health physics consequences of out-patient treatment of non-Hodgkin's lymphoma with 131I-radiolabeled anti-B1 antibody. 
  • Health status and quality of life in patients with early-stage Hodgkin's disease treated on Southwest Oncology Group Study 9133. 
  • Hepatic metastasis from neuroblastoma. 
  • High-dose areas are unintentionally created as a result of gap shifts when the prescribed dose in the two adjacent areas are different. 
  • High-dose, hyperfractionated, accelerated radiotherapy using a concurrent boost for the treatment of nonsmall cell lung cancer: unusual toxicity and promising early results. 
  • Hippocampal dose from stereotactic radiosurgery for 4 to 10 brain metastases: Risk factors, feasibility of dose reduction via re-optimization, and patient outcomes. 
  • Host regulation of MOPC 104E plasmacytoma after reduction of tumor burden by total body irradiation. 
  • How much radiation is the chemotherapy worth in advanced head and neck cancer? 
  • How should we describe the radioblologic effect of extracranial stereotactic radlosurgery: equivalent uniform dose or tumor control probability? 
  • Hyperfractionated radiation therapy in brain stem tumors. Results of treatment at the 7020 cGy dose level of Pediatric Oncology Group study #8495. 
  • Hyperthermia classic commentary: 'Arrhenius relationships from the molecule and cell to the clinic' by William Dewey, Int. J. Hyperthermia, 10:457-483, 1994. 
  • Hyperthermia: an overview of current progress and problems. 
  • IMRT treatment of anal cancer with a scrotal shield. 
  • Ice as a water-equivalent solid medium for brachytherapy dosimetric measurements. 
  • Image-guided procedures for intensity-modulated spinal radiosurgery. Technical note. 
  • Impact of consolidation radiation therapy in stage III-IV diffuse large B-cell lymphoma with negative post-chemotherapy radiologic imaging. 
  • Impact of dose calculation accuracy during optimization on lung IMRT plan quality. 
  • Impact of high-dose chemotherapy on the ability to deliver subsequent local-regional radiotherapy for breast cancer: analysis of Cancer and Leukemia Group B Protocol 9082. 
  • Impact of overall treatment time on survival and local control in patients with anal cancer: a pooled data analysis of Radiation Therapy Oncology Group trials 87-04 and 98-11. 
  • Impact of volumetric modulated arc therapy technique on treatment with partial breast irradiation. 
  • Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer. 
  • Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial. 
  • Improvements in prostate radiotherapy from the customization of beam directions. 
  • Improving Quality and Consistency in NRG Oncology Radiation Therapy Oncology Group 0631 for Spine Radiosurgery via Knowledge-Based Planning. 
  • In regard to Vasanathan et al. (Int J Radiat Oncol Biol Phys 2005;61:145-153). 
  • In regards to Wallner et al: (125)I versus (103)PD for low-risk prostate cancer: preliminary PSA outcomes from a prospective randomized multicenter trial (Int J Radiat Oncol Biol Phys 2003;57:1297-1303). 
  • Incorporating patient-specific CT-based ophthalmic anatomy in modeling iodine-125 eye plaque brachytherapy dose distributions. 
  • Incorporating single-side sparing in models for predicting parotid dose sparing in head and neck IMRT. 
  • Incorporation of functional imaging data in the evaluation of dose distributions using the generalized concept of equivalent uniform dose. 
  • Increased Number of Beam Angles Is Associated With Higher Cardiac Dose in Adjuvant Fixed Gantry Intensity Modulated Radiation Therapy of Left-Sided Breast Cancer. 
  • Influence of WR 2721 on radiation response of canine soft tissue sarcomas. 
  • Influence of coralline hydroxyapatite used as an ocular implant on the dose distribution of external beam photon radiation therapy. 
  • Input/output characteristics of a matrix ion-chamber electronic portal imaging device. 
  • Integral dose conservation in radiotherapy. 
  • Intensity-Modulated Radiation Therapy Is Not Associated with Perioperative or Survival Benefit over 3D-Conformal Radiotherapy for Rectal Cancer. 
  • Intensity-modulated radiation therapy for anal malignancies: a preliminary toxicity and disease outcomes analysis. 
  • Intensity-modulated radiation therapy in gynecologic malignancies. 
  • Intensity-modulated radiation therapy use for the localized treatment of thyroid cancer: Nationwide practice patterns and outcomes. 
  • Intensity-modulated radiotherapy optimization with gEUD-guided dose-volume objectives. 
  • Intensive induction chemotherapy and radiation for organ preservation in patients with advanced resectable head and neck carcinoma. 
  • Internal radiation for bile duct cancer. 
  • Interobserver variability leads to significant differences in quantifiers of prostate implant adequacy. 
  • Intraoperative electron beam radiation therapy for retroperitoneal soft tissue sarcoma. 
  • Intraoperative pelvic brachytherapy for treatment of locally advanced or recurrent colorectal cancer. 
  • Intraoperative radiation therapy. 
  • Intrathecal 131I-labeled antitenascin monoclonal antibody 81C6 treatment of patients with leptomeningeal neoplasms or primary brain tumor resection cavities with subarachnoid communication: phase I trial results. 
  • Intravitreal triamcinolone acetonide for radiation maculopathy after plaque radiotherapy for choroidal melanoma. 
  • Investigating the accuracy of microstereotactic-body-radiotherapy utilizing anatomically accurate 3D printed rodent-morphic dosimeters. 
  • Investigation of the feasibility of relative 3D dosimetry in the Radiologic Physics Center Head and Neck IMRT phantom using presage/optical-CT. 
  • Investigation of the support vector machine algorithm to predict lung radiation-induced pneumonitis. 
  • Iodine-125 interstitial irradiation of virally induced dog brain tumours. 
  • Ion therapy of prostate cancer: daily rectal dose reduction by application of spacer gel. 
  • Irradiation for locoregionally recurrent, never-irradiated oral cavity cancers. 
  • Is a 3-mm intrafractional margin sufficient for daily image-guided intensity-modulated radiation therapy of prostate cancer? 
  • Is a reduction in radiation lung volume and dose necessary with paclitaxel chemotherapy for node-positive breast cancer? 
  • Is a single isocenter sufficient for volumetric modulated arc therapy radiosurgery when multiple itracranial metastases are spatially dispersed? 
  • Is proton beam therapy better than standard radiation therapy? A paucity of practicality puts photons ahead of protons. 
  • Is there an increased risk of local recurrence under the heart block in patients with left-sided breast cancer? 
  • Knowledge of pathologically versus clinically negative lymph nodes is associated with reduced use of radioactive iodine post-thyroidectomy for low-risk papillary thyroid cancer. 
  • Late rectal bleeding following combined X-ray and proton high dose irradiation for patients with stages T3-T4 prostate carcinoma. 
  • Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors: a report from the Childhood Cancer Survivor Study. 
  • Limitations of silicon diodes for clinical electron dosimetry. 
  • Local excision of distal rectal cancer: an update of cancer and leukemia group B 8984. 
  • Localized carcinoma of the prostate (stages T1B, T1C, T2, and T3). Review of management with external beam radiation therapy. 
  • Long term survivors of childhood brain stem gliomas treated with hyperfractionated radiotherapy. Clinical characteristics and treatment related toxicities. The Pediatric Oncology Group. 
  • Long-term follow-Up of a randomized trial of two irradiation regimens for patients receiving allogeneic marrow transplants during first remission of acute myeloid leukemia. 
  • Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma. 
  • Long-term results of intraoperative electron beam irradiation (IOERT) for patients with unresectable pancreatic cancer. 
  • Long-term survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy. 
  • Low-dose consolidation radiation therapy for early stage unfavorable Hodgkin lymphoma. 
  • Low-dose preoperative radiation therapy for adenocarcinoma of the endometrium. A pilot study. 
  • Low-dose radiation for posttransplant lymphoproliferative disorder. 
  • Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation. 
  • Margin reduction from image guided radiation therapy for soft tissue sarcoma: Secondary analysis of Radiation Therapy Oncology Group 0630 results. 
  • Massive locally extensive prostate cancer. 
  • Methods for transferring patient and plan data between radiotherapy treatment planning systems. 
  • Microdosimetric analysis of alpha-particle-emitting targeted radiotherapeutics using histological images. 
  • Monte Carlo calculation of imaging doses from diagnostic multidetector CT and kilovoltage cone-beam CT as part of prostate cancer treatment plans. 
  • Monte Carlo-based dosimetry of head-and-neck patients treated with SIB-IMRT. 
  • Morbidity and Mortality Associated With Meningioma After Cranial Radiotherapy: A Report From the Childhood Cancer Survivor Study. 
  • Multimodal therapy of prostatic cancer. 
  • Multiple fraction-per-day radiotherapy for patients with brain stem tumors. 
  • Myocardial perfusion changes in patients irradiated for left-sided breast cancer and correlation with coronary artery distribution. 
  • Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer. 
  • Neoadjuvant chemoradiation for distal rectal cancer: 5-year updated results of a randomized phase 2 study of neoadjuvant combined modality chemoradiation for distal rectal cancer. 
  • Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. 
  • Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group study. 
  • New radiotherapy and chemoradiotherapy approaches for non-small-cell lung cancer. 
  • Nodal downstaging predicts survival following induction chemotherapy for stage IIIA (N2) non-small cell lung cancer in CALGB protocol #8935. 
  • Nonsurgical approach in stage I and stage II breast cancer. 
  • Novalis radiosurgery for metastatic spine tumors. 
  • Novel human IgG2b/murine chimeric antitenascin monoclonal antibody construct radiolabeled with 131I and administered into the surgically created resection cavity of patients with malignant glioma: phase I trial results. 
  • Number and orientations of beams in intensity-modulated radiation treatments. 
  • On relating the generalized equivalent uniform dose formalism to the linear-quadratic model. 
  • On the feasibility of polyurethane based 3D dosimeters with optical CT for dosimetric verification of low energy photon brachytherapy seeds. 
  • On the sensitivity of TG-119 and IROC credentialing to TPS commissioning errors. 
  • On the sensitivity of TG-119 and IROC credentialing to TPS commissioning errors. 
  • On-line re-optimization of prostate IMRT plans for adaptive radiation therapy. 
  • Optical-CT gel-dosimetry I: basic investigations. 
  • Optimization of intensity-modulated radiotherapy plans based on the equivalent uniform dose. 
  • Osteoradionecrosis and radiation dose to the mandible in patients with oropharyngeal cancer. 
  • Outlier identification in radiation therapy knowledge-based planning: A study of pelvic cases. 
  • Oxygen and Perfusion Kinetics in Response to Fractionated Radiation Therapy in FaDu Head and Neck Cancer Xenografts Are Related to Treatment Outcome. 
  • Palliative radiation therapy for metastatic Ewing sarcoma. 
  • Palliative thoracic radiotherapy in advanced lung cancer: A single institution experience. 
  • Pancreatic neuroendocrine tumors with involved surgical margins: prognostic factors and the role of adjuvant radiotherapy. 
  • Paraganglioma of the head and neck: long-term local control with radiotherapy. 
  • Parameter optimization in HN-IMRT for Elekta linacs. 
  • Parotid gland dose in intensity-modulated radiotherapy for head and neck cancer: is what you plan what you get? 
  • Patient safety and institutional review boards in multi-institutional dose escalation or expansion trials. 
  • Patterns of recurrence after trimodality therapy for esophageal cancer. 
  • Pediatric brain stem tumors: patterns of treatment failure and their implications for radiotherapy. 
  • Percentage of positive biopsies associated with freedom from biochemical recurrence after low-dose-rate prostate brachytherapy alone for clinically localized prostate cancer. 
  • Phase I study of accelerated conformal radiotherapy for stage I non-small-cell lung cancer in patients with pulmonary dysfunction: CALGB 39904. 
  • Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer. 
  • Phase II randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus: RTOG 0113. 
  • Phase II study of neoadjuvant bevacizumab and radiotherapy for resectable soft tissue sarcomas. 
  • Phase II study of neoadjuvant chemotherapy and radiation therapy with thoracotomy in the treatment of clinically staged IIIA non-small cell lung cancer. 
  • Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancer. 
  • Physical penumbra change of beam profile due to film digitization. 
  • Physics considerations for single-isocenter, volumetric modulated arc radiosurgery for treatment of multiple intracranial targets. 
  • Pixel response-based EPID dosimetry for patient specific QA. 
  • Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: a strategy for large-scale implementation for the treatment of carcinoma of the prostate. 
  • Point dose verification for intensity modulated radiosurgery using Clarkson's method. 
  • Point/Counterpoint. A 3D-conformal technique is better than IMRT or VMAT for lung SBRT. 
  • Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update. 
  • Postoperative prostate-specific antigen as a prognostic indicator in patients with margin-positive prostate cancer, undergoing adjuvant radiotherapy after radical prostatectomy. 
  • Potential of intensity-modulated radiotherapy to escalate doses to head-and-neck cancers: what is the maximal dose? 
  • Practice patterns in the delivery of radiation therapy after mastectomy among the University of California Athena Breast Health Network. 
  • Preclinical Evaluation of Promitil, a Radiation-Responsive Liposomal Formulation of Mitomycin C Prodrug, in Chemoradiotherapy. 
  • Preclinical assessment of comfort and secure fit of thermobrachytherapy surface applicator (TBSA) on volunteer subjects. 
  • Predicting radiotherapy-induced cardiac perfusion defects. 
  • Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy. 
  • Preoperative Single-Fraction Partial Breast Radiation Therapy: A Novel Phase 1, Dose-Escalation Protocol With Radiation Response Biomarkers. 
  • Preoperative chemoradiation for adenocarcinoma of the pancreas: excessive toxicity of prophylactic hepatic irradiation. 
  • Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group. 
  • Preoperative chemoradiation for patients with pancreatic cancer: toxicity of endobiliary stents. 
  • Preoperative chemotherapy and radiation therapy for locally advanced primary and recurrent rectal carcinoma. A report of surgical morbidity. 
  • Preoperative infusional chemoradiation and surgery with or without an electron beam intraoperative boost for advanced primary rectal cancer. 
  • Preoperative radiation therapy and chemotherapy for pulmonary blastoma: a case report. 
  • Preoperative radiotherapy and bevacizumab for angiosarcoma of the head and neck: two case studies. 
  • Preoperative single fraction partial breast radiotherapy for early-stage breast cancer. 
  • Pretreatment anemia is correlated with the reduced effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancer. 
  • Primary ocular adnexal mucosa-associated lymphoid tissue lymphoma (MALT): single institution experience in a large cohort of patients. 
  • Primary radiation therapy for early glottic cancer. 
  • Primary testicular lymphoma: the site matters. 
  • Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation. 
  • Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer. 
  • Prospective assessment of dosimetric/physiologic-based models for predicting radiation pneumonitis. 
  • Prospective trial of preoperative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal cancer. 
  • Prostate brachytherapy: a descriptive analysis from CaPSURE. 
  • Protocols for the dosimetry of high-energy photon and electron beams: a comparison of the IAEA TRS-398 and previous international codes of practice. International Atomic Energy Agency. 
  • Proton-beam, intensity-modulated, and/or intraoperative electron radiation therapy combined with aggressive anterior surgical resection for retroperitoneal sarcomas. 
  • Pulmonary toxicity in Stage III non-small cell lung cancer patients treated with high-dose (74 Gy) 3-dimensional conformal thoracic radiotherapy and concurrent chemotherapy following induction chemotherapy: a secondary analysis of Cancer and Leukemia Group B (CALGB) trial 30105. 
  • Quantification of prostate and seminal vesicle interfraction variation during IMRT. 
  • Quantifying the dosimetric trade-offs when using intensity-modulated radiotherapy to treat concave targets containing normal tissues. 
  • Quantifying the effect of intrafraction motion during breast IMRT planning and dose delivery. 
  • Quantitative analysis of the factors which affect the interpatient organ-at-risk dose sparing variation in IMRT plans. 
  • RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer. 
  • Radiation Therapy Oncology Group 0247: a randomized Phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer. 
  • Radiation Therapy for Solitary Plasmacytoma and Multiple Myeloma: Guidelines From the International Lymphoma Radiation Oncology Group. 
  • Radiation dose and cardiac risk in breast cancer treatment: An analysis of modern radiation therapy including community settings. 
  • Radiation dose considerations in the palliative treatment of locally advanced adenocarcinoma of the pancreas. 
  • Radiation dose estimations to the thorax using organ-based dose modulation. 
  • Radiation dose selection in Hodgkin's disease patients with large mediastinal adenopathy treated with combined modality therapy. 
  • Radiation dose to the neurovascular bundles or penile bulb does not predict erectile dysfunction after prostate brachytherapy. 
  • Radiation dose-volume effects in the stomach and small bowel. 
  • Radiation plus local hyperthermia versus radiation plus the combination of local and whole-body hyperthermia in canine sarcomas. 
  • Radiation synovectomy with 165Dy-FHMA: lymph node uptake and radiation dosimetry calculations. 
  • Radiation techniques for the treatment of Hodgkin's disease with combined modality therapy or radiation alone. 
  • Radiation therapy advances for treatment of anal cancer. 
  • Radiation therapy for control of soft-tissue sarcomas resected with positive margins. 
  • Radiation therapy for head and neck cancer in a patient with Takayasu's arteritis. 
  • Radiation therapy in the treatment of minor salivary gland tumors. 
  • Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication. 
  • Radiation-induced narrowing of the tracheobronchial tree: an in-depth analysis. 
  • Radioactive sources embedded in suture are associated with improved postimplant dosimetry in men treated with prostate brachytherapy. 
  • Radiologic appearance of the irradiated larynx. Part I. Expected changes. 
  • Radiosensitization of chemotherapy-refractory, locally advanced or locally recurrent breast cancer with trastuzumab: a phase II trial. 
  • Radiosurgery in the treatment of spinal metastases: tumor control, survival, and quality of life after helical tomotherapy. 
  • Radiotherapy in the treatment of patients with unresectable extrahepatic cholangiocarcinoma. 
  • Radiotherapy treatment plans with RapidArc for prostate cancer involving seminal vesicles and lymph nodes. 
  • Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: cancer and leukemia group B study 9431. 
  • Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105. 
  • Rapid-fractionation pre-operative chemoradiation for malignant periampullary neoplasms. 
  • Rationale of technical requirements for NRG-BR001: The first NCI-sponsored trial of SBRT for the treatment of multiple metastases. 
  • Re-examining TG-142 recommendations in light of modern techniques for linear accelerator based radiosurgery. 
  • Re: Dosimetric consequences of increased seed strength for I-125 prostate implants. Radiother Oncol. 2003 Sep;68(3):295-7. 
  • Real-time dose-rate monitoring with gynecologic brachytherapy: Results of an initial clinical trial. 
  • Receiver operating characteristic curves to assess predictors of radiation-induced symptomatic lung injury. 
  • Rectourethral fistula after combination radiotherapy for prostate cancer. 
  • Reduction in Tumor Volume by Cone Beam Computed Tomography Predicts Overall Survival in Non-Small Cell Lung Cancer Treated With Chemoradiation Therapy. 
  • Regional dose response to pulmonary irradiation using a manual method. 
  • Relating radiation-induced regional lung injury to changes in pulmonary function tests. 
  • Relation between pO2, 31P magnetic resonance spectroscopy parameters and treatment outcome in patients with high-grade soft tissue sarcomas treated with thermoradiotherapy. 
  • Relationship between the generalized equivalent uniform dose formulation and the Poisson statistics-based tumor control probability model. 
  • Resected pancreatic neuroendocrine tumors: patterns of failure and disease-related outcomes with or without radiotherapy. 
  • Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy. 
  • Response of canine oral carcinomas to heat and radiation. 
  • Results from the Quality Research in Radiation Oncology (QRRO) survey: Evaluation of dosimetric outcomes for low-dose-rate prostate brachytherapy. 
  • Results of a phase II trial of transrectal ultrasound-guided permanent radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate (radiation therapy oncology group 98-05). 
  • Retroperitoneal fibrosis following radiotherapy for stage I testicular seminoma. 
  • Reversible neurotoxicity following hyperfractionated radiation therapy of brain stem glioma. 
  • Risk of secondary malignancies after radiation therapy for breast cancer: Comprehensive results. 
  • Role of Gamma Knife surgery in the management of pineal region tumors. 
  • Routine use of approximately 60 Gy once-daily thoracic irradiation for patients with limited-stage small-cell lung cancer. 
  • Safety and Efficacy of Radiation Therapy in Advanced Melanoma Patients Treated With Ipilimumab. 
  • Salvage radiotherapy for rising or persistent PSA after radical prostatectomy. 
  • Sector laser photocoagulation for the prevention of macular edema after plaque radiotherapy for uveal melanoma: a pilot study. 
  • Seduced by dose? 
  • Selection of coplanar or noncoplanar beams using three-dimensional optimization based on maximum beam separation and minimized nontarget irradiation. 
  • Semiautomated head-and-neck IMRT planning using dose warping and scaling to robustly adapt plans in a knowledge database containing potentially suboptimal plans. 
  • Sensitivity of 3D Dose Verification to Multileaf Collimator Misalignments in Stereotactic Body Radiation Therapy of Spinal Tumor. 
  • Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiation. 
  • Similarities between static and rotational intensity-modulated plans. 
  • Simple Factors Associated With Radiation-Induced Lung Toxicity After Stereotactic Body Radiation Therapy of the Thorax: A Pooled Analysis of 88 Studies. 
  • Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas. I: dosimetric results. 
  • Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results. 
  • Speed and convergence properties of gradient algorithms for optimization of IMRT. 
  • Stage T3 prostate cancer: a nonrandomized comparison between definitive irradiation and induction hormonal manipulation plus prostatectomy. 
  • Stereotactic body radiotherapy for lesions of the spine and paraspinal regions. 
  • Stereotactic body radiotherapy reirradiation for recurrent epidural spinal metastases. 
  • Subsequent malignancies in children treated for Hodgkin's disease: associations with gender and radiation dose. 
  • Supratentorial malignant glioma: patterns of recurrence and implications for external beam local treatment. 
  • Surgery after organ preservation therapy. Analysis of wound complications. 
  • Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients. 
  • Synovectomy of the rheumatoid knee using intra-articular injection of dysprosium-165-ferric hydroxide macroaggregates. 
  • Systematic review: surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer. 
  • T4 rectal cancer treated with preoperative chemoradiation to the posterior pelvis followed by multivisceral resection: patterns of failure and limitations of treatment. 
  • Technical considerations in the application of intensity-modulated radiotherapy as a concomitant integrated boost for locally-advanced cervix cancer. 
  • Technology assessment: vigilance required. 
  • The 1999 patterns of care study of radiotherapy in localized prostate carcinoma: a comprehensive survey of prostate brachytherapy in the United States. 
  • The delivery of IMRT with a single physical modulator for multiple fields: a feasibility study for paranasal sinus cancer. 
  • The effect of the respiratory cycle on mediastinal and lung dimensions in Hodgkin's disease. Implications for radiotherapy gated to respiration. 
  • The evolving role of stereotactic radiosurgery and stereotactic radiation therapy for patients with spine tumors. 
  • The future of therapy for childhood rhabdomyosarcoma: clues from molecular biology. 
  • The impact of respiratory motion and treatment technique on stereotactic body radiation therapy for liver cancer. 
  • The importance of an isolated central nervous system relapse in children with acute lymphoblastic leukemia. 
  • The optimization and inherent limitations of 3D conformal radiotherapy treatment plans of the prostate. 
  • The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study. 
  • The role of androgen deprivation therapy combined with prostate brachytherapy. 
  • The role of functional imaging in the diagnosis and management of late normal tissue injury. 
  • The role of intraoperative radiation therapy in patients with pancreatic cancer. 
  • The role of whole brain radiation therapy in the management of melanoma brain metastases. 
  • The utility of non-axial treatment beam orientations for lower lobe lung cancers. 
  • Thermal characteristics of thermobrachytherapy surface applicators for treating chest wall recurrence. 
  • Three-Dimensional Dosimetric Validation of a Magnetic Resonance Guided Intensity Modulated Radiation Therapy System. 
  • Three-dimensional applicator system for carcinoma of the uterine cervix. 
  • Thyroid neoplasia following irradiation for medulloblastoma: report of two cases. 
  • Thyroid nodules and survivors of Hodgkin's disease. 
  • Toxicity of definitive and post-operative radiation following ipilimumab in non-small cell lung cancer. 
  • Transperineal templates for brachytherapy treatment of pelvic malignancies--a comparison of standard and customized templates. 
  • Treatment Guidelines for Preoperative Radiation Therapy for Retroperitoneal Sarcoma: Preliminary Consensus of an International Expert Panel. 
  • Treatment of autochthonous rat brain tumors with fractionated radiotherapy. The effects of graded radiation doses and of combined therapy with BCNU or steroids. 
  • Treatment of infants with malignant gliomas: the Pediatric Oncology Group experience. 
  • Treatment of rheumatoid synovitis of the knee with intraarticular injection of dysprosium 165-ferric hydroxide macroaggregates. 
  • Treatment planning for prostate brachytherapy using region of interest adjoint functions and a greedy heuristic. 
  • Treatment strategies in renal carcinoma. 
  • Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experience. 
  • Tumors of the central nervous system. Improvement in outcome through a multimodality approach. 
  • Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy. 
  • Unintended exposure in radiotherapy: identification of prominent causes. 
  • Update on brachytherapy in localized prostate cancer: the importance of dosimetry. 
  • Use of whole body hyperthermia as a method to heat inaccessible tumours uniformly: a phase III trial in canine brain masses. 
  • Using FDG-PET activity as a surrogate for tumor cell density and its effect on equivalent uniform dose calculation. 
  • Using FDG-PET to measure early treatment response in head and neck squamous cell carcinoma: quantifying intrinsic variability in order to understand treatment-induced change. 
  • Using patient data similarities to predict radiation pneumonitis via a self-organizing map. 
  • Using plasma transforming growth factor beta-1 during radiotherapy to select patients for dose escalation. 
  • Uterine Neoplasms. Clinical Practice Guidelines in Oncology. 
  • Utilizing knowledge from prior plans in the evaluation of quality assurance. 
  • Uveal melanoma treated with iodine-125 episcleral plaque: an analysis of dose on disease control and visual outcomes. 
  • Variability in the treatment of elderly patients with stage IIIA (N2) non-small-cell lung cancer. 
  • Variation in the definition of clinical target volumes for pelvic nodal conformal radiation therapy for prostate cancer. 
  • Volumetric arc intensity-modulated therapy for spine body radiotherapy: comparison with static intensity-modulated treatment. 
  • Volumetric-modulated arc therapy: effective and efficient end-to-end patient-specific quality assurance. 
  • Weekly paclitaxel and carboplatin induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck. 
  • [The mechanism of the antitumor effect of total/subtotal radiotherapy with non-tumoricidal doses of radiation]. 
• 

  Keywords of People

  • Allori, Alexander C, Assistant Professor of Surgery, Surgery, Plastic, Maxillofacial, and Oral Surgery
  • Barfield, Raymond Carlton, Professor of Pediatrics, Duke Science & Society
  • Charles, Hal Cecil, Associate Professor of Radiology, Radiology
  • Craciunescu, Oana, Associate Professor of Radiation Oncology, Radiation Oncology
  • Koontz, Bridget Fey, Associate Professor of Radiation Oncology, Radiation Oncology
  • MacFall, James R., Adjunct Professor in the Department of Radiology, Radiology
  • Mruthyunjaya, Prithvi, Adjunct Associate Professor in the Department of Ophthalmology, Ophthalmology, Vitreoretinal Diseases & Surgery
  • O'Daniel, Jennifer Colleen, Assistant Professor of Radiation Oncology, Radiation Oncology
  • Pang, Herbert, Adjunct Assistant Professor in the Department of Biostatistics and Bioinformatics, Biostatistics & Bioinformatics
  • Sampson, John Howard, Robert H., M.D. and Gloria Wilkins Professor of Neurosurgery, in the School of Medicine, Immunology
  • Stinnett, Sandra Sue, Associate Professor of Biostatistics and Bioinformatics, Biostatistics & Bioinformatics